- OPD 9 AM – 6 PM · Emergency 24×7
- Mayur Nagar, N-11, CIDCO, Chhatrapati Sambhajinagar
Home › Hemato-oncology › Stem Cell & Bone Marrow Transplant
Stem cell and bone marrow transplantation is a specialised medical procedure used to treat certain blood cancers, bone marrow disorders and other serious conditions.
It involves replacing damaged or diseased blood-forming stem cells with healthy stem cells collected from the patient or a suitable donor.
Stem cell transplant treatment may be recommended for certain patients with leukaemia, lymphoma, multiple myeloma and other blood-related conditions. The procedure can help restore healthy blood cell production after intensive treatment such as high-dose chemotherapy.
The need for a transplant depends on the patient’s diagnosis, disease stage, overall health and response to previous treatments. At Karnawat Cancer Hospital in Sambhajinagar, patients can consult an oncology specialist to understand their condition and discuss appropriate treatment options.
A stem cell transplant is a medical procedure in which healthy blood-forming stem cells are infused into the bloodstream to help restore the body’s ability to produce healthy blood cells.
Blood-forming stem cells are primarily found in the bone marrow. They develop into red blood cells, white blood cells and platelets, which are essential for carrying oxygen, fighting infections and preventing excessive bleeding.
Certain cancers and intensive cancer treatments can damage the bone marrow and affect normal blood cell production. A stem cell transplant can help restore this function by introducing healthy stem cells.
Stem cells used for transplantation may come from the patient’s own body or from a suitable donor. The source of the cells and the type of transplant depend on the patient’s medical condition and treatment plan.
A bone marrow transplant is a type of stem cell transplant in which blood-forming stem cells are collected from the bone marrow and given to a patient. Bone marrow is the soft tissue inside certain bones where blood cells are produced. When the bone marrow is damaged by disease or intensive treatment, transplantation may help restore healthy blood cell production.
Although the terms stem cell transplant and bone marrow transplant are often used interchangeably, they are not exactly the same. Stem cells can be collected from the bloodstream, bone marrow or umbilical cord blood. The term bone marrow transplant specifically refers to a transplant using stem cells collected from bone marrow. Both procedures aim to restore blood-forming function, but the source of the stem cells can differ.
Transplant?
Stem cell transplant is the broader term for procedures that use blood-forming stem cells to restore bone marrow function. Bone marrow transplant is one type of stem cell transplant.
The main difference is the source from which the stem cells are collected.
All three methods can provide blood-forming stem cells. The most appropriate source depends on the patient’s condition, transplant type, donor availability and medical considerations.
A stem cell or bone marrow transplant may be recommended when bone marrow is affected by cancer or another serious condition. Doctors assess diagnosis, disease status, overall health, and potential benefits.
Stem cell transplantation may be considered for selected patients with high-risk leukaemia, relapsed disease, or leukaemia that has not responded adequately to other treatments.
Patients with certain lymphoma subtypes may need stem cell transplantation when disease returns or does not respond to initial treatment. Autologous transplantation may be used in selected cases.
Autologous stem cell transplantation is an important treatment option for selected multiple myeloma patients, often following initial drug therapy to achieve deeper responses and improve disease control.
Transplantation may be considered for certain bone marrow failure syndromes, inherited blood disorders, and other conditions, depending on diagnosis, disease severity, health, benefits, and risks. Not everyone with blood cancer or a bone marrow disorder requires transplantation. Specialists carefully evaluate each patient’s diagnosis, disease status, overall health, and treatment options.
Stem cell transplantation is classified according to where the stem cells come from. The two main types are autologous and allogeneic transplantation.
An autologous stem cell transplant uses the patient’s own healthy blood-forming stem cells.
The stem cells are collected and stored before high-dose chemotherapy. After the intensive treatment, the stored stem cells are infused back into the patient’s bloodstream to help restore blood cell production.
Autologous transplantation is used for selected patients with conditions such as multiple myeloma and certain lymphomas.
Since the patient’s own cells are used, there is no risk of graft-versus-host disease. However, the procedure still carries risks, including infection, bleeding and other complications related to high-dose chemotherapy.
An allogeneic stem cell transplant uses blood-forming stem cells from another person, known as a donor.
The donor may be a relative or an unrelated person whose tissue characteristics are sufficiently compatible with the patient. A suitable donor match is assessed through human leukocyte antigen (HLA) testing.
Allogeneic transplantation may be used for selected patients with conditions such as leukaemia and certain other blood disorders.
Donor stem cells can help restore healthy blood cell production. In some blood cancers, donor immune cells may also recognise and attack remaining cancer cells. However, allogeneic transplantation carries the risk of graft-versus-host disease, in which donor immune cells attack the patient’s healthy tissues.
Before transplantation, doctors perform a detailed medical evaluation to determine whether the patient is suitable. Tests may include blood work, heart and lung assessments, kidney and liver function tests, imaging, and HLA testing for donor compatibility.
Stem cells may be collected from the bloodstream after medicines increase circulating stem cells. A specialised machine separates them from the blood. For bone marrow collection, cells are usually taken from the pelvic bone under anaesthesia.
Before transplantation, patients receive conditioning treatment, usually involving high-dose chemotherapy and sometimes radiation therapy. This treatment helps destroy cancerous or diseased cells and prepares the body to receive the transplanted stem cells.
After conditioning, collected stem cells are infused into the patient through an intravenous line or central venous catheter. The procedure is similar to a blood transfusion, without surgery. Stem cells travel through the bloodstream to the bone marrow.
Following infusion, transplanted stem cells settle in the bone marrow and begin producing new blood cells. This process, called engraftment, is monitored through regular blood tests. Patients may require medicines, transfusions, and infection-prevention measures during recovery.
Stem cell transplantation is used in the treatment of selected blood cancers and other conditions affecting blood-forming cells.
For certain cancers, high-dose chemotherapy can destroy cancer cells but also severely damage healthy bone marrow. A stem cell transplant helps restore blood cell production after this intensive treatment.
Depending on the disease, transplantation may be used as part of the initial treatment plan or when cancer returns or does not respond adequately to previous therapies. The role of transplantation differs across cancer types. It is an important option for selected patients with multiple myeloma, certain lymphomas and some types of leukaemia.
Stem cell transplantation is an intensive treatment that can cause short-term and long-term side effects. The risks vary depending on the type of transplant, conditioning treatment, donor compatibility, underlying disease and the patient’s overall health. Common Short-Term Side Effects Patients may experience fatigue, weakness, nausea, vomiting, loss of appetite, mouth sores, hair loss, diarrhoea and low blood cell counts following transplantation. Reduced blood cell production can also increase the risk of infections, bleeding and bruising. These effects are often related to the conditioning treatment and temporary suppression of the bone marrow.
Graft-Versus-Host Disease Graft-versus-host disease (GVHD) is a possible complication of an allogeneic stem cell transplant. It occurs when donor immune cells recognise the patient’s healthy tissues as foreign and attack them. GVHD can affect the skin, liver, digestive system and other organs. It may develop soon after transplantation or later during recovery. Doctors closely monitor patients and may use medicines to prevent or manage GVHD. Infections The risk of infection increases after transplantation because conditioning treatment and the transplant process can temporarily weaken the immune system. Patients may require preventive medicines, regular monitoring, vaccinations when appropriate, and precautions to reduce exposure to infections during the recovery period. Organ-Related Complications Some patients may develop complications involving organs such as the liver, kidneys, lungs, or heart. The risk can depend on the conditioning regimen, previous cancer treatments, underlying medical conditions, transplant type, and overall health. Doctors monitor organ function before and after transplantation to identify potential complications early.
Long-Term Side Effects Certain side effects may develop months or years after transplantation. These can include fertility problems, hormonal changes, cataracts, organ damage and an increased risk of certain secondary cancers. Long-term follow-up is important for monitoring health, identifying complications and providing appropriate treatment when needed.
Regular Follow-Up Not every patient experiences these side effects or complications. The transplant team provides regular follow-up care, including blood tests and other assessments, to monitor recovery and identify potential problems. Patients should promptly report new or unusual symptoms to their healthcare team.
Stem cell and bone marrow transplantation require specialised medical evaluation, careful treatment planning and close monitoring. Patients considering transplantation should understand the procedure, potential risks, donor requirements and expected recovery.
Karnawat Cancer Hospital in Sambhajinagar provides cancer care and oncology consultations. Patients can discuss their diagnosis, previous treatment records and whether stem cell transplantation may be appropriate for their condition. If you are looking for a stem cell transplant hospital in Sambhajinagar or a bone marrow transplant hospital in Sambhajinagar, consult an oncology specialist to understand the available treatment options and the next steps in your care.
A stem cell transplant is a procedure that replaces damaged or diseased blood-forming stem cells with healthy stem cells. The cells may come from the patient or a suitable donor and help restore normal blood cell production.
A bone marrow transplant is a type of stem cell transplant in which blood-forming stem cells are collected directly from bone marrow and infused into a patient. It may be used to treat selected blood cancers and bone marrow disorders.
A stem cell transplant generally involves medical evaluation, stem cell collection, conditioning treatment and stem cell infusion. After infusion, the cells travel to the bone marrow and begin producing new blood cells. Doctors monitor the patient closely during recovery.
In a bone marrow transplant, healthy stem cells are collected from the patient’s own bone marrow or a suitable donor. The patient receives conditioning treatment before the collected cells are infused into the bloodstream. The cells then travel to the bone marrow and help restore blood cell production.
Transplantation may be recommended for selected patients with leukaemia, lymphoma, multiple myeloma and certain bone marrow disorders. The decision depends on the disease, previous treatment response, overall health and the potential benefits and risks of the procedure.
transplant?
Stem cell transplant is the general term for procedures that use blood-forming stem cells. Bone marrow transplant is one type of stem cell transplant in which the cells are collected directly from bone marrow. Stem cells can also be collected from the bloodstream or umbilical cord blood.
Eligibility depends on the patient’s diagnosis, disease stage, previous treatments, overall health and ability to tolerate conditioning treatment. For an allogeneic transplant, doctors also assess whether a suitable donor is available.
Possible side effects include fatigue, nausea, vomiting, mouth sores, infections, bleeding and low blood cell counts. Allogeneic transplantation can also cause graft-versus-host disease. Some patients may experience long-term complications involving organ function or fertility.
Recovery varies according to the transplant type, conditioning treatment and the patient’s health. Blood cell production may recover over several weeks, while immune system recovery can take several months or longer. Regular medical follow-up is important throughout recovery.
The stem cell infusion itself is generally not painful and is similar to receiving a blood transfusion. However, the conditioning treatment and recovery period can cause discomfort and side effects. Bone marrow collection is performed under anaesthesia.
This page is for general information and does not replace a consultation. Treatment is decided by your oncologist after reviewing your reports.
Emergency & I.C.U. 24×7 · OPD 9 AM – 6 PM
Karnawat Cancer Hospital provides hemato-oncology care for patients with blood cancers and related blood and bone marrow disorders.
Leukemia is a type of blood cancer that begins in the blood-forming tissues, mainly the bone marrow.
Lymphoma is a type of blood cancer that develops in the lymphatic system, which is an important part of the body’s immune system.
Multiple myeloma is a type of blood cancer that develops in plasma cells, a type of white blood cell responsible for producing antibodies.
Consultations, second opinions and treatment planning. Emergency and I.C.U. care 24 hours a day.
Share your details and our team will call you to confirm a time.
